FAP and neoplasm: Yu et al. designed a nanoparticle technology that responds to the CAF membrane biomarker FAP-α and NIR laser irradiation to tackle this difficulty.The NPs contained photothermal IR-780 and tiny albumin-bound paclitaxel (HSA-PTX) with strong tumor-penetrating ability.